How to Reduce the Main Risk of Menopausal Hormone Therapy (MHT, HRT, HT) |Biomedgrid

Most societies with interest in the field of estrogen/progestogen-therapy in peri- and postmenopausal women have now agreed to give this important area of gynecology the name “Menopausal Hormone Therapy” (MHT) instead of “hormone replacement therapy” (HRT) or “hormone therapy” (HT). The different terminology includes different assessments, different rationales, of this therapeutic area. There remains still some confusion since the definition of “menopause” is the “last period”, but indeed this treatment is offered not only during the time of or after the last period but for example also is urgently needed for women with primary ovarian insufficiency (POI) (for example after chemotherapy) or after oophorectomy, i.e. during a long period in womens' life. Thus, the old term ‘HRT' is also still in use, even the usual treatment of peri- and postmenopausal women should not be seen as a “replacement” (R), but rather as a treatment of symptoms, as this is considered using in the term “hormone therapy” (HT).